Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.95 - $27.04 $1.07 Million - $1.71 Million
63,139 Added 16.74%
440,254 $11.9 Million
Q1 2024

May 15, 2024

BUY
$11.38 - $19.03 $133,293 - $222,898
11,713 Added 3.21%
377,115 $6.91 Million
Q4 2023

Feb 14, 2024

SELL
$6.29 - $15.72 $3.85 Million - $9.63 Million
-612,559 Reduced 62.64%
365,402 $4.48 Million
Q3 2023

Nov 14, 2023

SELL
$14.99 - $32.65 $1.85 Million - $4.04 Million
-123,742 Reduced 11.23%
977,961 $14.7 Million
Q2 2023

Aug 14, 2023

BUY
$29.76 - $46.14 $10.7 Million - $16.6 Million
360,239 Added 48.58%
1,101,703 $35.8 Million
Q1 2023

May 15, 2023

BUY
$38.09 - $57.79 $16.2 Million - $24.5 Million
424,811 Added 134.16%
741,464 $29 Million
Q4 2022

Feb 14, 2023

BUY
$40.54 - $56.2 $11.1 Million - $15.3 Million
273,014 Added 625.62%
316,653 $16.7 Million
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $1.61 Million - $2.15 Million
43,639 New
43,639 $1.97 Million
Q1 2022

May 16, 2022

SELL
$29.24 - $44.06 $228,247 - $343,932
-7,806 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$39.32 - $61.61 $306,931 - $480,927
7,806 New
7,806 $333,000
Q2 2021

Aug 13, 2021

SELL
$44.66 - $63.06 $1.84 Million - $2.6 Million
-41,288 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$46.31 - $62.7 $19.8 Million - $26.8 Million
-428,134 Reduced 91.2%
41,288 $2.09 Million
Q4 2020

Feb 16, 2021

BUY
$55.51 - $69.94 $26.1 Million - $32.8 Million
469,422 New
469,422 $29.6 Million
Q3 2020

Nov 16, 2020

SELL
$42.19 - $69.61 $416,668 - $687,468
-9,876 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$27.55 - $43.28 $272,083 - $427,433
9,876 New
9,876 $414,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.